Role of estrogen replacement therapy in memory enhancement and the prevention of neuronal loss associated with Alzheimer's disease

American Journal of Medicine

Volumn 103, Issue 3 A, 1997, Pages 19S-25S

  Simpkins, James W ^a   Green, Pattie S ^a   Gridley, Kelly E ^a   Singh, Meharvan ^a   De Fiebre, Nancyellen C ^a   Rajakumar, Gopal ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE; CHOLINE ACETYLTRANSFERASE; ESTRADIOL; ESTROGEN; MESSENGER RNA; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AVOIDANCE BEHAVIOR; CHOLINERGIC NERVE CELL; CONFERENCE PAPER; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; HUMAN; HUMAN CELL; HYPOGLYCEMIA; LEARNING; NERVE CELL NECROSIS; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; RAT; SPATIAL MEMORY;

EID: 0030818062     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00260-X     Document Type: Conference Paper

References (35)

1. Katzman R. Alzheimer's disease. N Engl J Med. 314:1986;964-973.
2. Katzman R. The prevalence and malignancy of Alzheimer's disease. A major killer. (Editorial.). Arch Neurol. 33:1976;217-218.
3. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn MEE, Buckwalter JG. Estrogen replacement therapy in older women: comparison between Alzheimer's disease cases and nondemented control subjects. Arch Neurol. 51:1994;896-900.
4. Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer's disease. Am J Epidemiol. 140:1994;256-261.
5. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn NM, Buckwalter JG. Estrogen replacement therapy in older women: comparisons between Alzheimer's disease cases and controls. Arch Neurol. 51:1994;896-900.
6. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 348:1996;429-432.
7. Fillit H, Weinreb H, Cholst I, Luine V, McEwen B, Amador R, Zabriskie J. Observations in a preliminary open trial of estradiol therapy for senile dementia - Alzheimer's type. Psychoneuroendocrinology. 11:1986;337-345.
8. Honjo H, Ogino Y, Naitoh K, et al. In vivo effects by estrone sulfate on the central nervous system - senile dementia (Alzheimer's type). Biochem. 34:1989;521-525.
9. Ohkura T, Isse K, Akazawa K, Hamamoto M, Yaoi Y, Hagino N. Low-dose estrogen replacement therapy for Alzheimer disease in women. J North Am Menopause Soc. 1:1994;125-130.
10. Luine VN, Khylchevskaya R, McEwen BS. Effect of gonadal steroids on activities of monoamine oxidase and choline acetylase in rat brain. Brain Res. 86:1975;293-306.
11. Luine V, Park D, Joh T, Reis D, McEwen B. Immunochemical demonstration of increased choline acetyltransferase concentration in rat preoptic area after estradiol administration. Brain Res. 191:1980;273-277.
12. Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol. 89:1985;484-490.
13. O'Malley CA, Hautamaki RD, Kelley M, Meyer EM. Effects of ovariectomy and estradiol benzoate on high affinity choline uptake, ach synthesis, and release from rat cerebral cortical synaptosomes. Brain Res. 403:1987;389-392.
14. Flicker C, Dean RL, Watkins DL, Fisher SK, Bartus RT. Behavioral and neurochemical effects following neurotoxic lesions of a major cholinergic input to the cerebral cortex in the rat. Pharmacol Biochem Behav. 18:1983;973-981.
15. Singh M, Meyer EM, Millard WJ, Simpkins JW. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in female Sprague-Dawley rats. Brain Res. 644:1994;305-312.
16. Rajakumar G, de Fiebre N, Taube J, Simpkins JW. Estradiol reduces cognitive decline caused by severe hypoglycemia. Neurosci Abstr. 21:1995;164.
17. Collerton D. Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience. 19:1986;1-28.
18. Miranda RC, Sohrabji F, Toran-Allerand CD. Presumptive estrogen target neurons express mRNAs for both the neurotrophins and neurotrophin receptors: a basis for potential development interactions of estrogen with the neurotrophins. Mol Cell Neurosci. 4:1993;510-525.
19. Sohrabji F, Miranda RC, Toran-Allerand CD. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci. 14:1994;459-471.
20. Sohrabji F, Green LA, Miranda RC, Toran-Allerand CD. Reciprocal regulation of estrogen and NGF receptors by their ligands in PC 12 cells. J Neurobiol. 25:1994;974-988.
21. Singh M, Meyer EM, Huang FS, Millard WJ, Simpkins JW. Ovariectomy reduces ChAT activity and NGF mRNA levels in the frontal cortex of female Sprague-Dawley Rats. Soc Neurosci Abstr. 19:1993;254.
22. Singh M, Meyer EM, Simpkins JW. The effects of ovariectomy and estradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal regions of the female Sprague-Dawley rat. Endocrinology. 136:1995;2320-2324.
23. Ratke A, Mambourg E, Singh M. Effects of estradiol on lutineizing hormone-releasing hormone in SK-N-SH neuroblastoraia cells. Neurosci Abstr. 21:1995;1394.
24. Singer CA, Strickland TM, Rogers KL, Dorsa DM. Estrogen protects primary cortical neurons from glutamate neurotoxicity. Neurosci. Lett. 212:1996;13-16.
25. Bishop J, Simpkins JW. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci. 5:1994;303-308.
26. Simpkins JW, Singh M, Bishop J. The potential role for estrogen-replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging. 15:1994;S195-S197.
27. Green PS, Bishop J, Simpkins JW. 17 α-Estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci. 17:1997;511-515.
28. Green PS, Gordon K, Simpkins JW. Phenolic A ring requirement for the neuroprotective effects of steroids. J Steroid Biochem Mol Pharm. 1997; in press.
29. Blessed G, Tomlinson BE, Roth M. The association between quantitative measures of dementia and of senile changes in the cerebral gray matter of elderly subjects. Br J Psych. 114:1968;797-811.
30. Behl C, Davis JB, Klier FG, Schubert D. Amyloid B peptide induces necrosis rather than apoptosis. Brain Res. 645:1994;253-264.
31. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL. Neurotoxicity of fragment of the amyloid precursor associated with Alzheimer's disease. Science. 245:1989;417-420.
32. Hensley K, Carney JM, Mattson MP, Aksenova M, Harris M, Wu JF, Floyd RA, Butterfield DA. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer's disease. Proc Natl Acad Sci USA. 91:1994;3270-3274.
33. Behl C, Widmann M, Trapp T, Holsboer F. 17 β-Estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun. 216:1995;473-482.
34. Green PS, Gridley KE, Simpkins JW. Estradiol protects against β-amyloid (25-35)-induced-toxcity in SK-N-SH human neuroblastoma cells. Neurosci Lett. 218:1996;165-168.
35. Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Molec Pharm. 51:1997;535-541.